+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 55Years - 75Years
All Genders
ID07633392

Evaluating NeoMayor Mobile Health App to Improve Cardiovascular Health in Older Chilean Adults A Randomized Controlled Trial with Coaching and Wearable Support

Led by University of Chile · Updated on 2026-10-20

240

Participants Needed

2

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating NeoMayor, a mobile health mHealth intervention designed to improve cardiovascular health in older adults aged 55 to 75 years who have an elevated cardiovascular risk. This multicenter randomized controlled trial conducted in Chile aims to assess the effectiveness of the NeoMayor smartphone app, which supports lifestyle changes in physical activity, diet, sleep, and mental well-being through a multidomain approach. The study also explores implementation strategies to support app engagement and adherence, focusing on cardiovascular health improvement using the Lifes Essential 8 Cardiovascular Health Index CVHI. Participants are randomly assigned in a 21 ratio to either receive the NeoMayor app intervention or a control group receiving standard health information and usual care. The NeoMayor app delivers personalized behavioral challenges and recommendations over a four-month period. Within the NeoMayor group, participants are further randomized to receive additional support via a human health coach, a wearable activity tracker, both, or neither. The coach provides monthly contact to assist app use, while the wearable device helps self-monitor physical activity. During the study, participants undergo assessments at the start and end of the four-month period, including cardiovascular health, cognitive performance, mood symptoms, quality of life, physical function, and urinary albumin-to-creatinine ratio. App engagement, adherence, retention, and sustained use are also monitored to understand implementation outcomes. The total participation time is approximately four months, with data collected to evaluate both clinical effectiveness and how well the app can be adopted and maintained in real-world settings.

CONDITIONS

Brief Title

Effectiveness and Implementation Evaluation of NeoMayor for Improving Cardiovascular Health in Chilean Older Adults

Research Team

G

General coordinator

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here